Provider Implicit Bias Impacts Pediatric Type 1 Diabetes Technology Recommendations in the United States: Findings from The Gatekeeper Study | Zendy

Ananta Addala | Zendy; Sarah J. Hanes | Zendy; Diaranjo | Zendy; David M. Maahs | Zendy; Korey K. Hood | Zendy

Open Access

Provider Implicit Bias Impacts Pediatric Type 1 Diabetes Technology Recommendations in the United States: Findings from The Gatekeeper Study

Author(s) -

Ananta Addala,

Sarah J. Hanes,

Diaranjo,

David M. Maahs,

Korey K. Hood

Publication year - 2021

Publication title -

journal of diabetes science and technology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.039

H-Index - 75

eISSN - 1932-3107

pISSN - 1932-2968

DOI - 10.1177/19322968211006476

Subject(s) - medicine , logistic regression , family medicine , demography , actuarial science , business , sociology

Diabetes technology use is associated with favorable type 1 diabetes (T1D) outcomes. American youth with public insurance, a proxy for low socioeconomic status, use less diabetes technology than those with private insurance. We aimed to evaluate the role of insurance-mediated provider implicit bias, defined as the systematic discrimination of youth with public insurance, on diabetes technology recommendations for youth with T1D in the United States.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research